ESR1 and breast carcinoma: (3) In tamoxifen-resistant breast cancer cells, the expression changes of many genes were similar to wild-type cells under estrogen treatment, suggesting that the ER’s function exists in tamoxifen-resistant cells, and explaining that fulvestrant treatment might still be valid when tamoxifen resistance occurs.